Earnings Preview: Alkermes to Report Financial Results Pre-market on October 24
$Alkermes(ALKS.US)$ is scheduled to release its financial results pre-market on October 24 ET. Earnings PreviewAnalysts estimate $Alkermes(ALKS.US)$ to post revenue of USD382.22M for 2024Q3, up 0.34%
Alkermes to Report Third Quarter Financial Results on October 24, 2024
H.C. Wainwright Maintains Alkermes(ALKS.US) With Hold Rating, Maintains Target Price $37
Assessing Alkermes' ALKS-2680: A Hold Rating Amidst Potential and Prudence in Sleep Disorder Treatment
Analysts Conflicted on These Healthcare Names: Nurix Therapeutics (NRIX) and Alkermes (ALKS)
Is Alkermes (ALKS) The Most Undervalued Quality Stock To Buy According To Analysts?